Charles River Laboratories Intl. Inc  

(Public, NYSE:CRL)   Watch this stock  
Find more results for CRL
-0.64 (-0.72%)
After Hours: 87.81 0.00 (0.00%)
Mar 23, 4:10PM EDT  
NYSE real-time data - Disclaimer
Currency in USD
Range 87.75 - 88.81
52 week 67.20 - 91.57
Open 88.42
Vol / Avg. 0.00/451,304.00
Mkt cap 4.18B
P/E 27.28
Div/yield     -
EPS 3.22
Shares 47.37M
Beta 1.01
Inst. own 101%
Feb 8, 2017
Q4 2016 Charles River Laboratories International Inc Earnings Release (Estimated)
More events from DailyFinance »    

Key stats and ratios

Q4 (Dec '16) 2016
Net profit margin 9.70% 9.28%
Operating margin 14.80% 14.12%
EBITD margin - 22.16%
Return on average assets 6.72% 6.53%
Return on average equity 21.05% 19.68%
Employees 11,000 -
CDP Score - -


251 Ballardvale St
WILMINGTON, MA 01887-1096
United States - Map
+1-781-2226000 (Phone)
+1-978-9885665 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money


Charles River Laboratories International, Inc. is an early-stage contract research company. The Company is engaged in laboratory animal medicine and science (research model technologies) and develop a portfolio of discovery and safety assessment services, both good laboratory practice (GLP) and non-GLP, which supports its clients from target identification through non-clinical development. The Company operates in three segments: Research Models and Services (RMS), Discovery and Safety Assessment (DSA), and Manufacturing Support (Manufacturing). The RMS segment includes Research Models and Research Model Services. The DSA segment includes Discovery Services and Safety Assessment. The Manufacturing segment includes Microbial Solutions, Avian, Biologics and Contract Manufacturing. The Company also provides a suite of products and services to support the Company's clients' manufacturing activities.

Officers and directors

James C. Foster Chairman of the Board, President, Chief Executive Officer
Age: 65
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
David R. Smith Chief Financial Officer, Corporate Executive Vice President, Chief Accounting Officer
Age: 50
Bio & Compensation  - Reuters
David P. Johst Corporate Executive Vice President - Human Resources, Chief Administrative Officer, General Counsel
Age: 54
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Davide A. Molho Corporate Executive Vice President, President - Global Research Models & Services and Preclinical Services Operations
Age: 46
Bio & Compensation  - Reuters
George M. Milne Jr., Ph.D. Lead Independent Director
Age: 72
Bio & Compensation  - Reuters
Robert J. Bertolini CPA Independent Director
Age: 55
Bio & Compensation  - Reuters
Stephen D. Chubb Independent Director
Age: 72
Bio & Compensation  - Reuters
Deborah Turner Kochevar Ph.D. Independent Director
Age: 59
Bio & Compensation  - Reuters
George E. Massaro Independent Director
Age: 68
Bio & Compensation  - Reuters